Get the Stockscreener App
94.51
0.96%
-0.92
Healthequity Inc stock is traded at $94.51, with a volume of 697.93K.
It is down -0.96% in the last 24 hours and up +0.13% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$95.43
Open:
$95.55
24h Volume:
697.93K
Relative Volume:
0.78
Market Cap:
$8.07B
Revenue:
$1.15B
Net Income/Loss:
$96.70M
P/E Ratio:
86.71
EPS:
1.09
Net Cash Flow:
$-161.99M
1W Performance:
-10.14%
1M Performance:
+0.13%
6M Performance:
-16.14%
1Y Performance:
-6.28%
1-Day Range:
$93.91
$96.35
1-Week Range:
$93.91
$104.94
52-Week Range:
$74.07
$116.65
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQY
Healthequity Inc
|
94.51 | 8.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
VEEV
Veeva Systems Inc
|
242.00 | 39.83B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.66 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.93 | 9.66B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
34.35 | 6.77B | 906.14M | -52.62M | 89.62M | -0.3621 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Invesco Ltd. Sells 80,338 Shares of HealthEquity, Inc. $HQY - MarketBeat
HealthEquity Inc. Reports Strong Q3 Earnings and Growth - TipRanks
HealthEquity (NASDAQ:HQY) Receives Outperform Rating from Barrington Research - MarketBeat
HealthEquity (NASDAQ:HQY) Price Target Raised to $129.00 at JPMorgan Chase & Co. - MarketBeat
Deutsche Bank Adjusts Price Target on HealthEquity to $120 From $117, Maintains Buy Rating - marketscreener.com
HealthEquity, Inc. (NASDAQ:HQY) Q3 2026 earnings call transcript - MSN
HealthEquity (NASDAQ:HQY) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
HealthEquity (NASDAQ:HQY) Receives Buy Rating from BTIG Research - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) Q3 2026 Earnings Call Transcript - Insider Monkey
Norges Bank Makes New Investment in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity (HQY): Analyst Maintains Rating and Raises Price Ta - GuruFocus
Can HealthEquity Inc. (2HE) stock sustain revenue momentumWeekly Investment Recap & Step-by-Step Swing Trade Plans - Newser
EverSource Wealth Advisors LLC Raises Stock Position in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity, Inc. $HQY Shares Sold by Brown Advisory Inc. - MarketBeat
Will HealthEquity Inc. (2HE) stock draw ESG focused fundsQuarterly Portfolio Report & Accurate Buy Signal Alerts - Newser
How HealthEquity Inc. (2HE) stock compares with tech leadersJuly 2025 Retail & Smart Allocation Stock Tips - Newser
How currency fluctuations impact HealthEquity Inc. stockMarket Rally & Reliable Breakout Forecasts - Newser
HealthEquity Inc (HQY) Q3 2026 Earnings Call Highlights: Robust Growth and Strategic ... By GuruFocus - Investing.com Canada
HealthEquity (NASDAQ:HQY) Updates FY 2026 Earnings Guidance - MarketBeat
HealthEquity (NASDAQ:HQY) Announces Quarterly Earnings Results - MarketBeat
Citizens Maintains HealthEquity (HQY) Market Outperform Recommendation - Nasdaq
Is HealthEquity Inc. (2HE) stock vulnerable to rate hikesMarket Activity Recap & Target Return Focused Stock Picks - Newser
BofA Securities reiterates Buy rating on HealthEquity stock, citing margin expansion By Investing.com - Investing.com South Africa
HealthEquity price target raised to $129 from $126 at JPMorgan - TipRanks
HealthEquity (HQY) Rating Maintained as 'Outperform' by Barringt - GuruFocus
HealthEquity (HQY) Analyst Rating Update: JP Morgan Raises Price Target | HQY Stock News - GuruFocus
HealthEquity Stock Gains as Q3 Earnings Beat Estimates, Revenues Up Y/Y - Yahoo Finance
BofA Securities reiterates Buy rating on HealthEquity stock, citing margin expansion - Investing.com Australia
Dr. Eboni Price-Haywood: Innovating Toward Health Equity - The EDU Ledger
HealthEquity stock maintains Market Perform rating at BMO after strong quarter By Investing.com - Investing.com South Africa
HealthEquity stock maintains Market Perform rating at BMO after strong quarter - Investing.com Australia
Why Have Healthequity Stocks Dipped Despite Growth? - TipRanks
Can HealthEquity Inc. (2HE) stock test all time highsJuly 2025 Short Interest & Long-Term Growth Plans - Newser
HealthEquity price target raised to $122 from $117 at Citizens JMP - TipRanks
HealthEquity stock price target raised to $122 by Citizens on strong earnings - Investing.com UK
BTIG Reiterates Buy Rating for HealthEquity (HQY) at $130 Target | HQY Stock News - GuruFocus
Healthequity Inc earnings beat by $0.10, revenue topped estimates By Investing.com - Investing.com Nigeria
HealthEquity raises 2026 revenue guidance to $1.302B-$1.312B as HSA assets grow 15% - MSN
HealthEquity: Fiscal Q3 Earnings Snapshot - New Haven Register
Decoding HealthEquity Inc (HQY): A Strategic SWOT Insight - GuruFocus
HealthEquity Inc. Reports Strong Q3 Financial Performance - TipRanks
Healthequity Inc earnings beat by $0.10, revenue topped estimates - Investing.com South Africa
HealthEquity (HQY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - sharewise.com
HealthEquity (HQY) Tops Q3 Earnings and Revenue Estimates - sharewise.com
HealthEquity, Inc. INC Q3 Profit Increases, Beats Estimates - Nasdaq
HealthEquity raises FY26 EPS view to $3.87-$3.95 from $3.74-$3.91 - TipRanks
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo Finance
HealthEquity (HQY) Earnings — Q3 2026: Profit Surge Despite Revenue & EPS Miss - Quiver Quantitative
Earnings call transcript: HealthEquity beats Q3 2026 forecasts, stock steady - Investing.com
Earnings call transcript: HealthEquity beats Q3 2026 forecasts, stock steady By Investing.com - Investing.com UK
HQY Updates Fiscal 2026 Outlook with Revised Revenue and EBITDA Expectations - GuruFocus
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Healthequity Inc Stock (HQY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ladd Delano | EVP, General Counsel |
Oct 20 '25 |
Sale |
92.07 |
1,500 |
138,105 |
76,979 |
10.49%
1.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):